ICON Reports 49% Increase in Revenue and 52% Increase in Operating Income and Raises 2008 Guidance
ICON (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for its second quarter ended June 30, 2008.
Net revenues for the quarter were $218.3 million, representing a 48.5% increase over net revenues of $147 million for the comparative quarter last year. Year–to–date, net revenues were $419.6 million, representing a 48.2% increase over the same period last year.
Income from operations was $24.4 million, compared to $16.1 million for the same quarter last year. Operating margin increased to 11.2% from 10.9%. Net income was $18.8 million or 62 cents per share on a diluted basis, compared with $13.3 million or 45 cents per share last year.
Year–to–date income from operations was $45.9 million, compared to $30.7 million last year representing a margin of 10.9% in both periods. Net income was $35.7 million or $1.19 per share, compared with $25.6 million or 86 cents last year.
Days sales outstanding were 58 days at June 30, 2008, compared to 66 days at December 31, 2007.
For the quarter ended June 30, 2008, cash provided by operating activities was $40.7 million and capital expenditure was $18.9 million. As a result, the company´s net cash amounted to $6.9 million at June 30, 2008, compared to net debt of $20.2 million at March 31, 2008.
"We are delighted with ICON´s second quarter performance", commented Chairman Dr. John Climax. "Revenue growth was very strong and operating margins showed good progress."
"It was another quarter of excellent bookings, which were $393 million gross and $337 million net" said CEO Peter Gray. "As a result of these strong business wins we continue to expand our global capability through opening new offices and hiring new staff and we now have in excess of 6500 staff working in 71 offices in 38 countries. The strength of demand for our global services has led us to increase our revenue guidance for 2008 to $870 – $890 million, and our EPS guidance to $2.46 – $2.52."
The company will hold its second quarter conference call today, July 22, 2008 at 9:00 EST [14:00 Ireland & UK]. This call and linked slide presentation can be accessed live from our website at http://www.iconplc.com. A recording will also be available on the website for 90 days following the call. In addition, a calendar of company events, including upcoming conference presentations, is available on our website, under "Investors". This calendar will be updated regularly.
The statements made in this Press Release may contain forward–looking statements that involve a number of risks and uncertainties. In addition to the matters described in this Press Release, the ability to maintain large client contracts or enter into new contracts, maintain client relationships and the ability to manage the opening of new offices, the integration of new business mergers and acquisitions, as well as other risks and uncertainties detailed from time to time in SEC reports filed by ICON, including its Form 20–F, F–1, S–8 and F–3, may affect the actual results achieved by ICON. ICON disclaims any intent or obligation to update these forward–looking statements.
The financial information presented herein has been prepared in accordance with U.S. GAAP.
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specializes in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I–IV clinical studies. With headquarters in Dublin, Ireland, ICON currently,operates from 71 locations in 38 countries and has approximately 6,500 employees. Further information is available at www.iconplc.com.
ICON plc Consolidated Income Statements (Unaudited) Three and Six Months ended June 30, 2008 and June 30, 2007 (Dollars, in thousands, except share and per share data) Three Months Ended Six Months Ended June 30, June 30, June 30, June 30, 2008 2007 2008 2007 Gross Revenue 316,592 207,383 600,445 394,123 Subcontractor costs 98,292 60,336 180,801 110,987 Net Revenue 218,300 147,047 419,644 283,136 Costs and expenses Direct costs 122,976 83,875 236,165 162,432 Selling, general and administrative 64,289 42,662 124,834 81,346 Depreciation and amortization 6,641 4,450 12,739 8,606 Total costs and expenses 193,906 130,987 373,738 252,384 Income from operations 24,394 16,060 45,906 30,752 Interest (expense) income (476) 1,019 (519) 2,063 Income before provision of income taxes 23,918 17,079 45,387 32,815 Provision for income taxes 4,891 3,758 9,138 7,186 Minority interest 206 6 534 48 Net income 18,821 13,315 35,715 25,581 Net income per ordinary share Basic $0.65 $0.46 $1.23 $0.89 Diluted $0.62 $0.45 $1.19 $0.86 Weighted average number of ordinary shares Basic 29,106,694 28,684,201 29,004,662 28,624,350 Diluted 30,156,563 29,685,489 30,083,989 29,597,671 ICON plc Summary Balance Sheet Data June 30, 2008 and December 31, 2007 (Dollars, in thousands) June 30, December 31, 2008 2007 (Unaudited) (Audited) Cash and short–term investments 114,389 118,633 Debt (107,400) (94,829) Net cash 6,989 23,804 Accounts receivable 221,480 129,865 Unbilled revenue 146,152 144,661 Payments on account (165,218) (96,553) Total 202,414 177,973 Working Capital 201,862 193,271 Total Assets 843,968 693,138 Shareholder´s Equity 447,157 388,400 Source: ICON plc Contact: Investor Relations 1–888–381–7923 or
Ciaran Murray CFO
+ 353 1 291 2000